A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia

被引:41
|
作者
Verhoeff, NPLG
Meyer, JH
Kecojevic, A
Hussey, D
Lewis, R
Tauscher, J
Zipursky, RB
Kapur, S
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Ctr Addict & Mental Hlth, Schizophrenia & Continuing Care Div, Toronto, ON M5T 1R8, Canada
基金
英国医学研究理事会;
关键词
psychosis; positive symptoms; negative symptoms; activation; dysphoria; autistic preoccupation;
D O I
10.1016/S0165-1781(00)00198-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several postmortem studies have reported regionally localized decreases in serotonin,, receptors (5-HT2AR) in schizophrenia. This was not confirmed by two recent [F-18]setoperone positron emission tomography (PET) studies. In these two studies relatively large regions of interest (ROIs) were used; hence, 5-HT2AR changes may have been missed in some brain areas. Therefore, data from one study were analyzed on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM). We also used this method to examine the relationship between 5-HT2AR binding potential (BP) and five PANSS-derived factors: negative, positive, activation, dysphoric and autistic preoccupation. Thirteen schizophrenic patients (10 antipsychotic-naive, 3 antipsychotic-free; 11 M, 2 F; age 31 +/- 7 years) and 35 age-matched control subjects (15 M, 20 F; age 30 +/- 7 years) were scanned. The 5-HT2AR BP was determined for each voxel using the pseudoequilibrium ratio method on PET data obtained between 65 and 90 min after [F-18]setoperone bolus injection. The resulting parametric 5-HT2AR BP images were spatially normalized using a ligand specific template. Analyses of covariance were done using SPM99 with age as covariate. In tests for the effect of schizophrenia and for partial correlations between 5-HT2AR BP and the five factors, corrected P values < 0.05 at cluster or voxel level were considered significant. No significant differences were detected between patients and control subjects, and no significant correlations were observed between 5-HT2AR BP and any of the five factors. Thus, in agreement with the previous ROI studies, voxel-by-voxel analysis confirmed the lack of substantial 5-HT2AR BP differences between schizophrenic patients and control subjects. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:123 / 135
页数:13
相关论文
共 50 条
  • [1] A voxel-by-voxel analysis of [18F] setoperone PET serotonin2A receptor data in schizophrenia
    Verhoeff, NPLG
    Meyer, JH
    Kecojevic, A
    Hussey, D
    Lewis, R
    Kapur, S
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 48S - 49S
  • [2] The effect of paroxetine on 5-HT2A receptors in depression:: An [18F]setoperone PET imaging study
    Meyer, JH
    Kapur, S
    Eisfeld, B
    Brown, GM
    Houle, S
    DaSilva, J
    Wilson, AA
    Rafi-Tari, S
    Mayberg, HS
    Kennedy, SH
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (01): : 78 - 85
  • [3] Serotonin 5-HT2 receptors in schizophrenia:: A PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects
    Lewis, R
    Kapur, S
    Jones, C
    DaSilva, J
    Brown, GM
    Wilson, AA
    Houle, S
    Zipursky, RB
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (01): : 72 - 78
  • [4] Concise and Scalable Radiosynthesis of (+)-[18F]MDL100907 as a Serotonin 5-HT2A Receptor Antagonist for PET
    Chavan, Lahu N.
    Voll, Ronald
    Sanchez, Mar M.
    Nye, Jonathon A.
    Goodman, Mark M.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2023, 14 (19): : 3694 - 3703
  • [5] Synthesis, radiofluorination and first evaluation of (±)-[18F]MDL 100907 as serotonin 5-HT2A receptor antagonist for PET
    Muehlhausen, Ute
    Ermert, Johannes
    Herth, Matthias M.
    Coenen, Heinz H.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 (1-2): : 6 - 12
  • [6] Synthesis, radiofluorination and first evaluation of [18F]fluorophenylsulfonyl- and [18F]fluorophenylsulfinyl-piperidines as serotonin 5-HT2A receptor antagonists for PET
    Muehlhausen, Ute
    Sihver, Wiebke
    Ermert, Johannes
    Coenen, Heinz H.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (05) : 605 - 614
  • [7] Direct comparison of [18F]MH.MZ and [18F]altanserin for 5-HT2A receptor imaging with PET
    Hansen, Hanne D.
    Ettrup, Anders
    Herth, Matthias M.
    Dyssegaard, Agnete
    Ratner, Cecilia
    Gillings, Nic
    Knudsen, Gitte M.
    [J]. SYNAPSE, 2013, 67 (06) : 328 - 337
  • [8] Synthesis, labelling and first evaluation of [18F]R91150 as a serotonin 5-HT2A receptor antagonist for PET
    Muehlhausen, Ute
    Ermert, Johannes
    Coenen, Heinz H.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 (1-2): : 13 - 22
  • [9] The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET
    J. H. Meyer
    R. Cho
    S. Kennedy
    S. Kapur
    [J]. Psychopharmacology, 1999, 144 : 279 - 281
  • [10] The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET
    Meyer, JH
    Cho, R
    Kennedy, S
    Kapur, S
    [J]. PSYCHOPHARMACOLOGY, 1999, 144 (03) : 279 - 281